Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-01
2005-11-01
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S540000, C514S595000, C514S619000, C514S621000, C514S636000, C514S654000, C544S386000, C544S400000, C544S403000, C560S025000, C560S034000, C560S035000, C560S041000, C560S158000, C560S163000, C560S168000, C564S156000
Reexamination Certificate
active
06960588
ABSTRACT:
Compounds of formula (I)in which M, B1, B2, B3, B4, B5, B6, A1, A2, A3, A4, A5, A6, K1 and K2 have the meanings as indicated in the description, are novel effective tryptase inhibitors.
REFERENCES:
patent: 95/32945 (1995-12-01), None
patent: 96/09297 (1996-03-01), None
patent: 98/04537 (1998-02-01), None
patent: 99/12918 (1999-03-01), None
patent: 99/24395 (1999-05-01), None
patent: 99/24407 (1999-05-01), None
patent: 99/40083 (1999-08-01), None
Hawley's Condensed Chemical Dictionary, Twelfth ed., p. 594, Van Nostrand Reinhold © 1993.
McGraw-Hill Dictionary of Chemical Terms, p. 200, McGraw-Hill, Inc. © 1985.
Concise Encyclopedia Chemistry, p. 490, Walter de Gruyter & Co. © 1993.
Rodbotten et al, “Stereoselective Synthesis of Alkynylglycines and a,a'-Alkynyl-Bridged Bis(glycines)” Acta Chemica Scandinavica, vol. 51, pp. 873-880, (1997).
Crisp et al, “Elaboration of the Side-Chain of Amino Acid Derivatives by Palladium Catalysed Couplings” Tetrahedron, vol. 53(51), pp. 17489-17500 (1997).
Burgess, “Mast Cell Tryptase as a Target for Drug Design” Drug News Perspectives, vol. 13(3), pp. 147-157 (Apr. 2000).
Wright et al, “Inhibition of Allergen-Induced Pulmonary Responses by the Selective Tryptase Inhibitor 1,5-bis-{4-[(3-Carbamidoyl-benzenesulfonylamino)-methyl]-phenoxy}-pentane (AMG-126737)” Biochemical Pharmacology, vol. 58, pp. 1989-1996 (1999).
West, Anthony R. “Solid State Chemistry and its Applications” Wiley, New York, pp. 358 and 365 (1988).
Rice, K.D., et al., “Inhibitors of Tryptase for the Treatment of Mast Cell-Mediated Diseases”,Current Pharmaceutical Design, V. 4, No. 5, pp. 381-396, (1998).
Krishna, et al., “Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma”,J. Allergy Clin. Immunol., Jun., 2001, pp. 1039-1045.
Rice, et al., “Dibasic Inhibitors of human mast cell tryptase. Part 2: Structure-Activity Relationships and Requirements for Potent Activity”, Bioorganic & Medicinal Chemistry Letters 10, pp. 2361-2366 (2000).
Altana Pharma AG
Goldberg Joshua B.
McGee Sheldon M.
Nath & Associates PLLC
Raymond Richard L.
LandOfFree
Tryptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tryptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tryptase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3485436